ArticleInfection2026
Horizontal transfer of ΦHKU.vir and its role in the evolution of acapsular emm89 group A Streptococcus in Taiwan.
Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Meeting the future at the Munich conference ESCMID-Global 2026.Infection · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionThe global resurgence of scarlet fever and invasive group A Streptococcus (GAS) infections has been noted over the past decade. In East Asia, specifically in Hong Kong and China, emm12 isolates that acquired prophage ΦHKU.vir, which carried SSA, SpeC, and Spd1 exotoxins, were over-presented in scarlet fever cases. The prevalence of ssa-positive emm12 isolates was increased significantly in Taiwan; however, it remains unclear whether this increase is mediated by the horizontal transfer of ΦHKU.vir homologs or the expansion of Hong Kong scarlet fever-associated emm12 isolates. MATERIALS AND
methodsThis study included 240 non-emm1 isolates in Taiwan during 2009-2023. The genome and prophage sequences of clinical isolates were analyzed by whole genome sequencing.
resultsThe prophages carried ssa, speC, and spd1 in Taiwan emm12 isolates shared high nucleotide sequence identity with ΦHKU.vir. All analyzed emm12 isolates in Taiwan were phylogenetically closely related to Hong Kong emm12 isolates, suggesting that Taiwan ssa-positive emm12 isolates shared a common origin with those from Hong Kong. This study further identified ΦHKU.vir homologs in emm90 and acapsular emm89 isolates. Although the acquisition of ΦHKU.vir is related to the expansion of emm12 isolates in Hong Kong, this study suggests that the prophage exotoxin SSA did not have significant roles in enhancing bacterial cytotoxicity and intracelluar survival of the acapsular emm89 strains.
conclusionsThe acquisition of prophages is important for the evolution of GAS. Monitoring the expansion of ΦHKU.vir in non-emm1/emm12 isolates is essential, as studying its impact on GAS pathogenicity will help in preventing and controlling GAS infections.
Indexed as
Identifiers
40996673What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.